Bi-specific T cell engagers (BiTEs) are a class of artificial bispecific monoclonal antibodies that are designed to direct the body's immune system to target and destroy cancer cells. BiTEs consist of two distinct binding domains: one that binds to a specific antigen on the surface of cancer cells and another that binds to the CD3 receptor on T cells.
